BOSTON--(BUSINESS WIRE)--OvaScience™, a fertility company focused on the discovery, development and commercialization of novel treatments for infertility, announced today that Michelle Dipp, M.D., Ph.D., chief executive officer of OvaScience, will present at the Shanghai CEO Conference, being held March 28-29 at The Peninsula Shanghai in Shanghai.
About OvaScience
OvaScience is a privately-held fertility company focused on the discovery, development and commercialization of novel treatments for infertility. OvaScience was co-founded by Rich Aldrich, Michelle Dipp, M.D., Ph.D., and Christoph Westphal, M.D., Ph.D., of Longwood Fund, and Professors Jonathan Tilly, Ph.D., Massachusetts General Hospital and Harvard Medical School, and David Sinclair, Ph.D., Harvard Medical School.